Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) EBT Margin: 2010-2025

Historic EBT Margin for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to 4.02%.

  • OptimizeRx's EBT Margin rose 506800.0% to 4.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.54%, marking a year-over-year increase of 393400.0%. This contributed to the annual value of 21.04% for FY2024, which is 141400.0% up from last year.
  • OptimizeRx's EBT Margin amounted to 4.02% in Q3 2025, which was up 506800.0% from 5.87% recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's EBT Margin registered a high of 6.83% during Q4 2024, and its lowest value of 49.2% during Q1 2023.
  • Over the past 5 years, OptimizeRx's median EBT Margin value was 17.54% (recorded in 2023), while the average stood at 16.99%.
  • Per our database at Business Quant, OptimizeRx's EBT Margin crashed by -397300bps in 2023 and then skyrocketed by 506800bps in 2025.
  • Over the past 5 years, OptimizeRx's EBT Margin (Quarter) stood at 3.07% in 2021, then tumbled by -154bps to 1.66% in 2022, then tumbled by -2396bps to 41.38% in 2023, then skyrocketed by 117bps to 6.83% in 2024, then tumbled by -41bps to 4.02% in 2025.
  • Its last three reported values are 4.02% in Q3 2025, 5.87% for Q2 2025, and 14.98% during Q1 2025.